Search is Powered by Google
Multiple Sclerosis News

Society Joins Medical Research Awards

Main Category: Multiple Sclerosis
Article Date: 22 Sep 2008 - 14:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The MS Society has been recognised as the only charity in the country to join a new awards initiative by the Fulbright Commission which aims to develop the talent of some of Britain's most promising medical researchers.

Today, at a service to mark the 60th anniversary of the Fulbright Treaty, the Fulbright Commission announced the first wave of new awards.

Supported by UK universities, institutes of higher education and the MS Society, the new awards will increase by 30% the scholarships it gives by 2010 to over 60. The awards aim to support the British and American higher education systems to increase the exchange of post graduate students, researchers and faculty.

The MS Society's award - the Fulbright Multiple Sclerosis Society Research Award - enables a British researcher to study in the US.

Simon Gillespie, chief executive of the MS Society, said: "Our support for the Fulbright Commission awards recognises the MS Society's commitment to furthering vital research into the cause and effects of multiple sclerosis. Supporting expert researchers will help us discover effective treatments, and ultimately a cure, for MS."

In welcoming the announcement of the new award, the Prime Minister, Gordon Brown, said:

"It is particularly pleasing to see one of the UK's leading charities in the forefront of this important initiative. The Multiple Sclerosis Society does vital work across the whole of the UK and this new fellowship is an important part of the Society's aim to beat MS."

MS Society




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
MS Damage May Be Reversed By Leukemia Drug
23 Oct 2008
Researchers in the UK found that alemtuzumab, a drug initially developed to treat leukemia, stopped the advance of multiple sclerosis (MS) in patients with early stage active relapsing-remitting multiple sclerosis (RRMS)...


Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

An MS Drug Back on the Market image An MS Drug Back on the Market

After being suspended from the market for safety reasons, natalizumab is again available for the treatment of multiple sclerosis. Safeguards are in place because of a small risk in developing a serious brain infection. Should you consider taking this drug...

View more videos...